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Background: Liver cancer is the second most-frequent cause of cancer death in Korea. Hepatitis B virus (HBV)
infection is a major cause of liver cancer, and this disease is effectively prevented by HBV vaccination. This study
was conducted to investigate factors associated with the lack of HBV vaccine uptake in the general adult male
population in Korea.
Methods: Data of men who participated in a nationwide cross-sectional interview survey were analyzed. A total of
2,174 men 40 years of age and older were interviewed between 2006 and 2008. None of the participants was
infected with HBV or was experiencing sequelae of an HBV infection.
Results: Only half (50.4%) of the men received one or more dose of the three-dose series of HBV vaccinations, and
32.5% received all three doses. Compared with men who had completed the vaccination regimen, non-vaccinated
men were more likely to lack supplemental medical insurance for cancer (odds ratio = 0.66, 95% confidence
interval: 0.52–0.84), have lower incomes (p-trend = 0.010), and be less educated (p-trend = 0.021). Lower education
was also more prevalent in the non-vaccinated group compared with the incompletely vaccinated group. Those
who had completed the vaccination regimen were likely to be more educated than those in the incompletely
vaccinated group (p-trend = 0.044). The most commonly cited reason for not obtaining the HBV vaccine was lack
of knowledge regarding the need for the vaccination. The number of men who cited this reason decreased as a
function of education.
Conclusions: It is important to develop strategic interventions targeted at less-educated men to increase uptake of
a complete three-dose series of HBV vaccinations as a primary approach to preventing liver cancer.
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In 2009, liver cancer was the second most-frequent cause
of cancer death in the Republic of Korea (33.0/100,000
men and 11.4/100,000 women). In the same year, 47.9/
100,000 men and 16.2/100,000 women developed liver
cancer, accounting for 12.0% of cancer incidence in men
and 4.3% in women. Although the 5-year survival rate for
liver cancer has been increasing, it remains low compared* Correspondence: jkjun@ncc.re.kr
1National Cancer Control Institute, National Cancer Centre, 323 Ilsan-ro,
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reproduction in any medium, provided the orwith other cancer types [1]. Chronic hepatitis B virus
(HBV) infection is a major risk factor for development of
liver cancer [2]. Of the 6,027 cases of hepatocellular
carcinoma (HCC), 4,856 were attributed to HBV infection,
accounting for 68.1% of HCC cases and deaths in Korea
[3]. Although its prevalence has decreased from 8.6% in
1980 [4] to 3.2% in 2009 [5], the Republic of Korea is a
HBV endemic area.
Worldwide, the rate of liver cancer development due to
chronic HBV infection was 0.1%/person-year in 1997 [6].
In Korea, the rate was 0.8%/year, and the 5-year cumulative
incidence was 3% in 2009 [4]. Another study conducted in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to 1992, 26% of HBV-infected individuals developed pri-
mary liver cancer [7].
The HBV vaccine was the first cancer-preventive
vaccine, which prevented liver cancer [2]. To reduce the
disease burden of HBV infection, a catch-up vaccination
program for adults was conducted in Korea. The first
catch-up program, implemented in 1985, targeted gov-
ernment employees, teachers, and their dependents. It
was followed by the mass HBV vaccination campaign,
conducted by the Korean government in 1988, targeting
school-aged children and adolescents. In 1995, the na-
tionwide HBV vaccination program for infants, using a
0, 1, and 6 month vaccine schedule, was implemented by
the National Immunization Program as part of the Com-
municable Diseases Prevention Act. However, a catch-up
vaccination program for adults has not been conducted
since the first in 1985. Although vertical transmission of
HBV is the main source of infection [8], horizontal
transmission is also important in HBV-endemic areas
[9]. In Korea, HBV transmission occurs commonly in
adulthood, which could be prevented by HBV vaccin-
ation. This includes the spread of infection through
sexual contact, non-sexual transmission among family
members in the same household, direct contact during
adulthood, and occupational/health-care related sources
[8,10,11]. Therefore, catch-up vaccination of adults is
critical for the control of HBV infection and subsequent
liver cancer [8,10].
In 2009, in Korea, the prevalence of hepatitis B surface
antigen (HBsAg) and its sequelae was much higher
among adult male compared with adult women or teen-
agers [4], who had been chosen as the target group in
the nationwide HBV vaccination program [12]. This sug-
gests that the adult male population in Korea is at high
risk for HBV infection and subsequent sequelae. Studies
of the determinants of HBV vaccination in the general
adult population are rare and focus on high-risk groups
[13,14]. Therefore, this study was conducted to investi-
gate factors associated with HBV vaccine uptake in the
general adult male population in Korea.
Methods
Study population and data
The Korean National Cancer Screening Survey (KNCSS)
is an annual nationwide population-based cross-sectional
interview survey using multi-stage random sampling to
investigate participation rates in screening for gastric,
liver, colorectal, breast, and cervical cancers in repre-
sentative samples. Based on target populations identified
in an organized cancer screening program conducted by
the Republic of Korea, cancer-free men 40 years and older
and cancer-free women 30 years and older comprise the
KNCSS-eligible population. Data on total number ofparticipants, response rate, and general characteristics of
the participants were discussed by Lee, et al. [10]. In-
formed consent was obtained from all participants. The
present study analyzed the data of men who participated
in the KNCSS between 2006 and 2008. Among the 2,441
men included initially, we excluded 152 subjects who, by
self-report, had existing health problems related to hepa-
titis infection, (i.e., liver cirrhosis), were HBsAg-positive,
and/or had chronic infection associated with hepatitis C.
We further excluded 52 men due to the presence of hepa-
titis B surface antibodies (anti-HBs) prior to vaccination
as well as 63 others due to missing information pertaining
to major variables. Data from 2,174 men were used in the
final analyses.
Vaccination status was classified into three categories
according to self-reported information on the number of
doses of HBV vaccine received. Complete vaccination
was defined as receiving the three-dose series of HBV
vaccines, incomplete vaccination was defined as receiv-
ing either one or two doses, and non-vaccinated was
defined as having never been vaccinated against HBV.
Sociodemographic characteristics, including age, area of
residence, supplemental medical insurance for cancer,
monthly income, highest level of education, self-
reported health status, occupation, and marital status
were considered as independent variables. Monthly indi-
vidual income was classified into four categories: ≤$999,
$1,000–$1,999, $2,000–$3,499, and ≥$3,500 (US currency).
Non-vaccinated men were asked to choose one of the fol-
lowing reasons for not being vaccinated: “Did not know I
need HBV vaccination”, “Put it off due to feeling annoyed
about it”, “Forgot”, “Lack of time”, “Did not know the
severity of the sequelae of HBV infection”, and “Other”.
Statistical analysis
Polychotomous logistic regression was used to identify
factors associated with complete and incomplete vaccin-
ation [15], and logistic regression was used to identify
the factors that differentiated between the complete and
the incomplete-vaccination groups. Interaction tests
were also conducted by including interaction terms be-
tween independent variables. The distribution of the
reasons for being non-vaccinated was analyzed as a
function of highest level of education achieved. All stat-
istical analyses were performed using the SAS software
version 9.1 (SAS Inc., Cary, North Carolina, USA). This
study was approved by the Institutional Review Board of
the National Cancer Center, Korea.
Results
A total of 2,174 men aged 40 years and older who partic-
ipated in the KNCSS between 2006 and 2008 were in-
cluded in our analysis. Sociodemographic characteristics
are shown in Table 1. About 73% were in their 40s and
Table 1 Baseline sociodemographic characteristics of
2,174 participants, Korean National Cancer Screening
Survey, 2006–2008
Variables n (%)
Age (years)
40−49 962 (44.3)
50−59 621 (28.6)
60−69 467 (21.5)
70−80 124 (5.7)
Area of residence*
Metropolitan 1,025 (47.2)
Urban 905 (41.6)
Rural 244 (11.2)
Supplemental medical insurance for cancer
Yes 1,375 (63.3)
No 788 (36.3)
Don't know 11 (0.5)
Monthly individual income (USD)
≤ 999 324 (14.9)
1,000-1,999 614 (28.2)
2,000-3,499 899 (41.4)
≥ 3,500 337 (15.5)
Level of education (years)
≤ 11 660 (30.4)
12-15 1,038 (47.8)
≥ 16 476 (21.9)
Self-reported health status
Good 1,437 (66.1)
Moderate 551 (25.3)
Poor 186 (8.6)
Occupation
Managerial and professional 416 (19.1)
Service and sales 830 (38.2)
Routine and manual 656 (30.2)
Long-term unemployed 272 (12.5)
Marital status
Married 2,030 (93.4)
Unmarried 144 (6.6)
*Metropolitan population ≥ 1.2 million; Urban population ≥ 50,000; Rural
population < 50,000.
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cancer. About 15% reported a monthly individual in-
come of $999 or less, and 30.4% had 11 or fewer years of
education (Table 1).
Among the men who participated in the study, 7.5%
received one dose of HBV vaccine, 10.4% received two
doses, and 32.5% received all three doses (data not
shown). In other words, approximately 64% of the 1,093men who began the vaccination series completed it. The
rate at which participants completed the vaccination
series decreased as a function of age; 34.4% of the men
in their 40s completed the series, while only 21.8% of
men between the ages of 70 and 80 did so (Figure 1).
The relationship between HBV vaccine uptake and
sociodemographic factors is presented in Table 2. The
higher level of education was correlated with both the
complete and incomplete HBV vaccination when com-
pared with the non-vaccinated group (p-trend = 0.021
and < 0.001, respectively). Lower monthly individual in-
come was also associated with a lower rate of complete
vaccination (p-trend = 0.010) compared to that in un-
vaccinated men. Men who did not have supplemental
medical insurance for cancer were less likely to be com-
pletely vaccinated compared with those who were not
vaccinated at all (odds ratio = 0.66, 95% confidence
interval: 0.52–0.84) (Table 2).
Duration of education was related to complete vaccin-
ation compared with incomplete vaccination; as educa-
tion level decreased, the rate of complete vaccination
decreased significantly (p-trend = 0.044, Table 3). Add-
itionally, men between 60 and 69 years of age were more
likely to receive the full three-dose regimen than were
those 40–49 years of age and those who felt their health
status was poor completely vaccinated more (Table 3).
Table 4 shows the relationship between reasons for be-
ing non-vaccinated and the level of education. The most
common reason for being non-vaccinated was no know-
ledge of the need for HBV vaccination, (cited by 40.3%
of non-vaccinated men), followed by “Put it off due to
feeling annoyed about it,” (19.8%), “Lack of time,”
(18.0%), “Forgot,” (10.2%), and “Did not know the sever-
ity of HBV infection” (6.7%). Nearly half (46.5%) of those
men with up to 11 years of education responded no
knowledge of the need for HBV vaccination as the rea-
son for being non-vaccinated. This decreased to 32.6%
among men who had complete 16 or more years of edu-
cation. Finally, the proportion that responded “Lack of
time” increased nearly two-fold among men with 16 or
more years of education compared with those who had
11 or fewer years of education, from 10.4% to 22.1%
(Table 4).
Discussion
This is the first study to investigate the factors associated
with HBV vaccine uptake, an effective medical interven-
tion for the prevention of liver cancer in the general adult
male population in Korea. In the current study, factors as-
sociated with complete HBV vaccination included higher
income, higher level of education, and supplemental med-
ical insurance for cancer. Level of education was signifi-
cantly associated with incomplete versus non-vaccinated
status with complete versus incomplete vaccination status.
Figure 1 Rate of vaccination series completion of hepatitis B virus (HBV) according to age among 2,174 men, Korean National Cancer
Screening Survey, 2006–2008. The complete vaccination rate was 32.5%, and 50.4% received one dose of the HBV vaccine.
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recommended for maximum effectiveness. Indeed, after
receiving the complete three-dosage series of HBV vac-
cination, seroprotection rates approached 100% among
healthy children and 95% among healthy adults [16]. In
Korea, HBV vaccination is offered by a wide range of
healthcare facilities, including local public health clinics,
primary healthcare settings, and tertiary hospital facil-
ities and the costs of HBV vaccination for adults are
relatively low (3–30 $US). HBV vaccine costs are consid-
erably lower when administered in public health clinics
than in private hospitals. However, half of the men in
the present study had never been vaccinated against
HBV, and only 32.5% of the participants received the
complete three-dose vaccination, despite the relatively
high incidence of HBV infection, liver cirrhosis, and liver
cancer among men in Korea. It is noteworthy that 39.8%
of Korean women received the complete vaccination, a
higher rate than among Korean men. One reason for
this difference might be the fact that the program for
the prevention of vertical HBV transmission targeted all
pregnant women in Korea [17].
To address the secondary prevention of liver cancer,
the National Cancer Screening Program in Korea began
an initiative for liver cancer screening in 2003. The pro-
gram provides liver cancer screening (alpha-fetoprotein
and ultrasonography) every 6 months for persons aged
40 or older who are positive for HBsAg, anti-HCV, or
liver cirrhosis [18]. Although the screening program was
implemented for secondary prevention, the importance
of the primary prevention of liver cancer through HBV
vaccination has not been sufficiently emphasized or
targeted at the adult population.
Level of education is strongly related to the amount of
health information sought and understood, especially inthe context of cancer-related issues. Indeed, educational
level can influence health-communication behaviors [19]
and the acquisition and integration of new information
[20]. In this study, a higher level of education was posi-
tively associated with HBV vaccine uptake and it was
also positively correlated with completing the three-
dosage HBV series vaccination. Similarly, a study of im-
migrants to the United States showed that attainment of
higher levels of education had a positive effect on HBV
vaccination uptake [5]. Thus, it may be suggested that a
higher level of education is important for increasing
HBV vaccine uptake among immigrants and the general
population, particularly in countries that provide na-
tional health insurance coverage, including Korea.
Completion of the three-dosage HBV vaccination
series has been associated with adherence to medical
recommendations. Education has been reported to influ-
ence physician–patient interaction, and patients with
higher education levels tend to be more likely to adhere
to medical treatment, thereby leading to better health
outcomes [21]. Higher income and having supplemental
medical insurance for cancer have been shown to in-
crease both accessibility to health care services and the
quality of care [22]. HBV infection in adulthood is com-
mon in high-prevalence areas such as Korea [9], and
those with low socioeconomic status have a higher inci-
dence of HBV infection [23]. Taking these factors into
consideration, the low rates of HBV vaccination among
people who are less educated, have lower incomes, and/
or are not covered by supplemental insurance for cancer
continue to be issues that need to be resolved.
Our study revealed that the most common reason for
not being vaccinated was lack of fundamental knowledge
regarding the necessity of HBV vaccination, which was
cited by 40% of non-vaccinated participants. Similarly, a
Table 2 Factors associated with being non-vaccinated versus completely† and incompletely* vaccinated against
hepatitis B virus‡ among 2,174 men, Korean National Cancer Screening Survey, 2006–2008
Complete vaccination Incomplete vaccination
OR (95% CI) p-trend OR (95% CI) p-trend
Age (years)
40−49 1.00 (referent) 0.322 1.00 (referent) 0.334
50−59 1.19 (0.93–1.52) 1.19 (0.88-1.61)
60−69 0.88 (0.63–1.23) 1.42 (0.95-2.12)
70−80 0.64 (0.37–1.11) 0.87 (0.43-1.77)
Area of residence
Metropolitan 1.00 (referent) 0.228 1.00 (referent) 0.686
Urban 1.05 (0.85–1.30) 0.87 (0.67-1.12)
Rural 1.26 (0.90–1.76) 1.29 (0.87-1.92)
Supplemental medical insurance for cancer
Yes 1.00 (referent) 1.00 (referent)
No 0.66 (0.52–0.84) 0.78 (0.59-1.05)
Monthly individual income (USD)
≤999 0.62 (0.41–0.92) 0.010 0.60 (0.35-1.01) 0.150
1,000–1,999 0.72 (0.51–1.01) 1.02 (0.67-1.53)
2,000–3,499 0.78 (0.57–1.06) 1.00 (0.68-1.46)
≥3,500 1.00 (referent) 1.00 (referent)
Duration of education (years)
≤11 0.66 (0.47–0.93) 0.021 0.43 (0.28-0.65) <0.001
12–15 0.70 (0.53–0.92) 0.62 (0.45-0.85)
≥16 1.00 (referent) 1.00 (referent)
Self–reported health status
Good 1.00 (referent) 0.877 1.00 (referent) 0.290
Moderate 1.11 (0.89–1.40) 0.96 (0.73-1.28)
Poor 0.83 (0.56–1.22) 1.41 (0.93-2.15)
Occupation
Managerial and professional 1.00 (referent) 1.00 (referent)
Service and sales 0.84 (0.63–1.11) 0.78 (0.56-1.10)
Routine and manual 1.01 (0.73–1.41) 0.94 (0.64-1.40)
Long–term unemployed 1.13 (0.73–1.75) 0.90 (0.52-1.55)
Marital status
Married 1.00 (referent) 1.00 (referent)
Unmarried 0.74 (0.47–1.16) 0.57 (0.31-1.07)
*Incomplete vaccination: received one or two doses of HBV vaccine.
†Complete vaccination: received the three-dosage HBV series vaccine.
‡Adjusted for list variables, type of health insurance, number of family members, smoking and drinking status and survey year.
OR: Odds ratio, CI: Confidence interval.
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vaccination recommendations was the main barrier to
becoming vaccinated [24]. Moreover, as the level of edu-
cation decreased, the proportion of men answering “Did
not know I need HBV vaccination” increased. This find-
ing may reflect disparities in how healthcare information
is communicated. People with lower education levelstend to be less aware of their hepatitis-infection status
when compared with more educated people [25]. This in
turn could affect liver cancer screening, because only
high-risk groups, such as hepatitis carriers or liver cir-
rhosis patients, are targeted by the National Cancer
Screening Program in Korea. As a result, it is not sur-
prising that the burden of liver disease is much greater
Table 3 Factors associated with complete* compared with
incomplete† vaccination‡ status among 2,174 men,
Korean National Cancer Screening Survey, 2006–2008
Incomplete vaccination† vs.
Complete vaccination*
OR (95% CI) p-trend
Age (years)
40−49 1.00 (referent) 0.128
50−59 1.00 (0.73–1.37)
60−69 1.60 (1.03–2.48)
70−80 1.27 (0.57–2.81)
Area of residence
Metropolitan 1.00 (referent) 0.561
Urban 0.83 (0.63–1.09)
Rural 1.01 (0.66–1.55)
Supplemental medical insurance for
cancer
Yes 1.00 (referent)
No 1.19 (0.86–1.64)
Monthly individual income (USD)
≤999 1.01 (0.58–1.76) 0.567
1,000–1,999 1.45 (0.93–2.24)
2,000–3,499 1.32 (0.89–1.96)
≥3,500 1.00 (referent)
Duration of education (years)
≤11 0.63 (0.40–0.98) 0.044
12-15 0.86 (0.62–1.21)
≥16 1.00 (referent)
Self-reported health status
Good 1.00 (referent) 0.311
Moderate 0.86 (0.63–1.16)
Poor 1.68 (1.04–2.71)
Occupation
Managerial and professional 1.00 (referent)
Service and sales 0.93 (0.65–1.32)
Routine and manual 0.90 (0.60–1.37)
Long-term unemployed 0.81 (0.46–1.45)
Marital status
Married 1.00 (referent)
Unmarried 0.75 (0.38–1.50)
*Incomplete vaccination: received one or two doses of HBV vaccine.
†Complete vaccination: received the three-dose HBV series vaccine.
‡Adjusted for list variables, type of health insurance, number of family
members, smoking and drinking status and survey year.
OR: odds ratio, CI: confidence interval.
Table 4 Reasons for not being vaccinated against
hepatitis B virus (HBV) according to the level of
education among 1,081 unvaccinated men, Korean
National Cancer Screening Survey, 2006–2008
Reasons Total (%)
(n = 1,081)
Duration of education (years)
≤11(%) 12-15(%) ≥16(%)
(n = 385) (n = 515) (n = 181)
Did not know I need
HBV vaccination
40.3 46.5 38.5 32.6
Put it off due to
feeling annoyed
about it
19.8 17.4 21.4 20.4
Forgot 10.2 9.9 8.5 15.5
Lack of time 18.0 10.4 22.3 22.1
Did not know the
severity of the sequelae
of HBV infection
6.7 9.4 4.9 6.1
Other 5.0 6.5 4.5 3.3
Park et al. BMC Infectious Diseases 2013, 13:218 Page 6 of 8
http://www.biomedcentral.com/1471-2334/13/218among less educated people. In Korea, inequality in liver
cancer mortality exists; higher mortality rates due to
liver cancer have been associated with lower levels of
education [26]. Our results indicate the importance of
focus efforts on health education of less educated groups
and underscore the necessity of increasing HBV vaccin-
ation uptake.
This study has several potential limitations. HBV infec-
tion status, which was used as an exclusion criterion, was
based on self-reports of previous HBV infection instead of
the results of serology tests. Therefore, we did not confirm
whether participants had been exposed to previous acute or
chronic infection with HBV (HBsAg and anti-HBc), intro-
ducing the possibility of erroneous data resulting from in-
formation bias. Additionally, data on vaccination history
and sociodemographic characteristics were based solely on
self-reporting. Measurement of serum total anti-HBs may
be a more reliable means of determining the vaccination
status of the participants. However, considering 10-15% of
those who complete three-dosage series of HBV vaccine fail
to response (anti-Hbs level below 10 mIU/ml) [27], it also
has some limitations. We did not review participants’ me-
dical records and consequently could not verify HBV vac-
cination status. Previous studies have reported different
results regarding the reliability of self-reported vaccination
history. Some suggested that self-reported vaccination his-
tory and personal information are reliable in that they are
consistent with the health information documented in
medical records [28,29] but a study have found opposite
results [30]. Information bias may have led to inaccurate
information about vaccination status. Furthermore, despite
the fact that both recombinant and plasma-derived HBV
vaccines were used in Korea until 2004, we did not ask par-
ticipants about the type of HBV vaccine received. The type
of vaccine administered determines which one of two
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applied when vaccinating with recombinant HBV, whereas
the 0, 1, 2 month schedule is applied when using plasma-
derived vaccine. Such differences between the two HBV
vaccines may have affected the accuracy of the reports of
vaccination history.
Despite these limitations, this study has several
strengths. First, by identifying the predictors of incomplete
and complete HBV vaccination, our results will be useful
in developing strategies to increasing HBV vaccination up-
take in the general adult male population. Second, the re-
sults are representative of the Korean male 40 years of age
or older due to our use of a population-based sampling
approach.
HBV vaccination is an important intervention used to
decrease the incidence of liver cancer, and universal
HBV vaccination is conducted in many Asian countries
[21]. According to our results, the rate of HBV vaccin-
ation among Korean men aged 40 years or older was
low between 2006 and 2008. HBV vaccination uptake
was related to level of education, supplemental medical
insurance for cancer, and monthly income; findings
showed that educational level was associated with
complete vaccine uptake among men who had started
the HBV vaccination series. Lack of knowledge of the
necessity of HBV vaccination was the most common
reason for non-vaccinated status, and data showed that
this was influenced by participants’ educational level. Al-
though only 1–5% of the adult population are chronically
infected following an acute infection [27], common means
of horizontal transmission (i.e., sexual contact, non-sexual
transmission, occupational/health-care related routes) are
very common in developing and endemic countries [6].
Therefore, adults should also be encouraged to receive
HBV vaccination to prevent HBV transmission by devel-
opment of herd immunity. Although the Korean govern-
ment has conducted HBV vaccination programs for
primary prevention of liver cancer, certain classes of adults
are neglected because the focus is restricted to children.
Thus, additional health promotion and education strat-
egies are needed to enhance HBV vaccine uptake; these
strategies should target specifically men with a lower level
of education.
Conclusions
Hepatitis B virus (HBV) infection and its sequelae are
major global health problems. Although vertical trans-
mission of HBV is the main source of infection, horizon-
tal transmission is also important in HBV-endemic
areas, especially in Korea, where HBV infection com-
monly occurs during adulthood. To increase the rate of
complete HBV vaccination it may be necessary to de-
velop tailored approaches that take into account the
various factors associated with vaccine uptake. In themale population, the level of education has been consist-
ently associated with complete vaccination compared with
non- and incomplete vaccination status. A lack of aware-
ness about the necessity of HBV vaccination was the most
common reason for being non-vaccinated; the proportion
of men citing this reason decreased as a function of edu-
cation. Strategies aimed at increasing knowledge of the
need for HBV vaccination and increasing complete vaccin-
ation rates should be developed and targeted at Korea’s
less educated male population, as vaccination is the pri-
mary preventative intervention for liver cancer.
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